Company / PP&E per Share
Voyager Therapeutics, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.24
FY2025
5-year range
$0.24 / $0.59
FY2021-FY2025
Trend
-26.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has declined for 5 consecutive years, from $0.69 in FY2020 to $0.24 in FY2025.
Based on SEC 10-K filings.
0.24 in FY2025 with a 5-year CAGR of -19.0%.
Declined from $0.43 to $0.24 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -20.1%
- 5-Year CAGR
- -19.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Voyager Therapeutics, Inc.'s pp&e per share has declined for 5 consecutive years.
- In FY2025, pp&e per share decreased 26.2% year-over-year.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.24 | -26.2% |
| FY2024 | $0.33 | -23.9% |
| FY2023 | $0.43 | -9.3% |
| FY2022 | $0.47 | -19.7% |
| FY2021 | $0.59 | -15.0% |
| FY2020 | $0.69 | +24.2% |
| FY2019 | $0.56 | +37.4% |
| FY2018 | $0.40 | +0.7% |
| FY2017 | $0.40 | +26.9% |
| FY2016 | $0.32 | -92.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026